ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche: FTC Requests More Information On Illumina Offer

DOW JONES NEWSWIRES U.S. regulators have asked Roche Holding AG (ROG.VX, RHHBY) for additional information about its proposed takeover of Illumina Inc. (ILMN), the drug maker said Tuesday. The Federal Trade Commission's request reflects antitrust concerns about Roche's microarray business and would delay any acquisition another 10 days after Roche complies with the second request under U.S. law. Roche is still working to complete its hostile takeover of Illumina, which continues to oppose the Swiss company's offer as inadequate. Illumina makes machines that use blood or tissue samples to decode a person's entire genetic makeup in about a week--a process known as DNA sequencing. Shares of the takeover target closed at $50.34 Tuesday and were unchanged after hours. Roche's cash offer values the company at $44.50 a share. -By Drew FitzGerald, Dow Jones Newswires; 212-416-2909; [email protected]

Stock News for Illumina (ILMN)
DateTimeHeadline
01/19/201717:57:23Statement of Changes in Beneficial Ownership (4)
01/17/201706:30:00Illumina to Announce Fourth Quarter and Fiscal Year 2016 Financial...
01/12/201708:00:00Illumina, NRGene Collaborate to Accelerate Development of New...
01/11/201716:03:39Current Report Filing (8-k)
01/09/201719:10:00IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities...
01/09/201717:35:00Illumina and Bio-Rad Launch Solution for Single-Cell Genomic...
01/09/201717:30:00Illumina Introduces the NovaSeq Series—a New Architecture Designed t...
01/09/201709:00:00IBM and Illumina Partner to Standardize Genomic Data Interpretation
01/09/201708:45:00Philips and Illumina join forces to offer integrated genomics...
01/05/201716:05:00GRAIL Plans to Raise in Excess of $1B in Series B Funding
01/04/201710:22:00Leading Genetic Testing Companies Join Forces to Launch the Coalition...
01/03/201709:00:00Illumina Taps Garret Hampton, One of the World’s Leading Clinical G...
12/28/201622:00:00INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have...
12/27/201615:03:00ILMN LOSS NOTICE: Rosen Law Firm Reminds Illumina, Inc. Investors...
12/27/201606:30:00Illumina to Webcast Live Presentation at the J.P. Morgan Annual...
12/23/201615:22:00SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors...
12/20/201614:11:00SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On...
12/20/201614:02:00The Law Offices of Howard G. Smith Announces the Filing of a...
12/20/201609:00:00Illumina Names Jonathan Seaton as Senior Vice President for Corporate...
12/19/201621:23:00IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities...

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US